Understanding the Impact of COVID-19 on Chronic Lymphocytic Leukemia (CLL) Caregiving and Related Resource Needs.
Diliara BagautdinovaKelsey C BacharzCarma L BylundMaria Sae-HauElisa S WeissMichelle RajotteGreg LincolnTaylor S VasquezNaomi D ParkerKevin B WrightCarla L FisherPublished in: Journal of clinical medicine (2023)
Chronic lymphocytic leukemia (CLL) caregivers play a central role in disease management-a role that has been heightened during the COVID-19 pandemic given the healthcare system's reliance on frontline family caregivers and CLL patients' increased risk of infection and mortality. Using a mixed-method design, we investigated the impact of the pandemic on CLL caregivers (Aim 1) and their perceived resource needs (Aim 2): 575 CLL caregivers responded to an online survey; 12 spousal CLL caregivers were interviewed. Two open-ended survey items were thematically analyzed and compared with interview findings. Aim 1 results showed that two years into the pandemic, CLL caregivers continue to struggle with coping with distress, living in isolation, and losing in-person care opportunities . Caregivers described experiencing increasing caregiving burden, realizing the vaccine may not work or didn't work for their loved one with CLL, feeling cautiously hopeful about EVUSHELD , and dealing with unsupportive/skeptical individuals . Aim 2 results indicate that CLL caregivers needed reliable, ongoing information about COVID-19 risk, information about and access to vaccination, safety/precautionary measures, and monoclonal infusions . Findings illustrate ongoing challenges facing CLL caregivers and provide an agenda to better support the caregivers of this vulnerable population during the COVID-19 pandemic.
Keyphrases
- chronic lymphocytic leukemia
- palliative care
- coronavirus disease
- sars cov
- healthcare
- end stage renal disease
- chronic kidney disease
- depressive symptoms
- mental health
- risk factors
- prognostic factors
- social support
- cardiovascular disease
- public health
- ejection fraction
- coronary artery disease
- mass spectrometry
- quality improvement
- cardiovascular events
- type diabetes
- chronic pain
- health insurance
- respiratory syndrome coronavirus
- single molecule